Drag a card by its title · ⚙ to size, swap or remove

The company

Immunovant, Inc.

IMVT · Nasdaq

Health CareBiotechnologyNot moving yet

IMVT stood above a rising 150-day average in 47 of the last 52 weekly readings, and has been out of that trend for the last 2 weeks. It is 20.9% below that average now. Biotechnology: 15% of its 561 stocks in an uptrend (−17 points in four weeks); Health Care: 25% (−11 points in four weeks).

SEC filings

Statistics

Rotation: Not moving yet
Weeks in an uptrend: out for 2
Industry in uptrend: 15% -17 in 4 wk
Insider buys, 12 months: $350.0M
Insider sales, 12 months: $30.8M
Officials’ trades on record: 0
Institutions holding: 212 (+12)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 47 of 52 weeks.

17 Apr – 16 Oct

Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months1

Sale orders, 12 months41

Buyers · sellers1 · 10

Who	Did	Shares	Traded
Jay S. StoutChief Technology Officer	sold	2,213at $32.06	7 Oct 2026filed 9 Oct 2026
Jay S. StoutChief Technology Officer	sold	1,596at $32.06	7 Oct 2026filed 9 Oct 2026
Melanie GloriaChief Operating Officer	sold	2,241at $32.06	7 Oct 2026filed 9 Oct 2026
Tuyl Christopher VanChief Legal Officer	sold	1,327at $32.06	7 Oct 2026filed 9 Oct 2026
Eric VenkerChief Executive Officer	sold	3,506at $34.11	2 Oct 2026filed 5 Oct 2026
Tuyl Christopher VanChief Legal Officer	sold	2,846at $36.36	23 Sep 2026filed 25 Sep 2026
Atul PandeDirector	sold	1,500at $43.27	28 Aug 2026filed 28 Aug 2026
Melanie GloriaChief Operating Officer	sold	3,056at $44.16	20 Aug 2026filed 21 Aug 2026
Atul PandeDirector	sold	1,500at $39.80	24 Jul 2026filed 24 Jul 2026
Tiago GiraoChief Financial Officer	sold	6,798at $38.69	23 Jul 2026filed 24 Jul 2026
Jay S. StoutChief Technology Officer	sold	2,857at $38.69	23 Jul 2026filed 24 Jul 2026
Jay S. StoutChief Technology Officer	sold	1,906at $39.53	8 Jul 2026filed 10 Jul 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders212+12 on the quarter

New · exited40 · 28

Reported value$4.1B

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

Manager	Shares	Change
FMR LLCreduced · filed 13 Aug 2026	16,186,469$623.7M	-761,419−4.5%
Deep Track Capital, LPreduced · filed 14 Aug 2026	9,341,151$359.9M	-2,185,820−19.0%
BlackRock, Inc.added · filed 7 Aug 2026	7,180,897$276.7M	+606,400+9.2%
FARALLON CAPITAL MANAGEMENT, L.L.C.added · filed 14 Aug 2026	5,805,000$223.7M	+4,259,000+275.5%
BAKER BROS. ADVISORS LPreduced · filed 14 Aug 2026	5,435,220$209.4M	-22,661−0.4%
STATE STREET CORPadded · filed 7 Aug 2026	4,617,005$177.9M	+79,076+1.7%
MORGAN STANLEYadded · filed 13 Aug 2026	4,534,833$174.7M	+657,956+17.0%
TCG Crossover Management, LLCunchanged · filed 14 Aug 2026	4,457,988$171.8M	00.0%
VANGUARD PORTFOLIO MANAGEMENT LLCadded · filed 13 Aug 2026	3,910,509$150.7M	+205,604+5.5%
VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026	3,638,681$140.2M	+18,631+0.5%